4D Molecular Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +144.0% | -50.6% | +94.8% | +32.5% | -82.7% | +562.3% | -99.8% | +230,194.6% | |
| – | +35.3% | +110.9% | +37.0% | -94.3% | +28.5% | +2,402.5% | +45.5% | -94.6% | |
| – | – | – | – | – | -82.7% | -2,540.8% | – | – | |
| – | +35.3% | +138.8% | +20.9% | +15.7% | +30.8% | +21.0% | +45.5% | +38.5% | |
| – | +76.8% | +125.3% | +24.1% | +62.5% | +17.5% | +10.9% | +27.6% | +5.3% | |
| – | +43.8% | -22.4% | -9.4% | +418.5% | +26.6% | -67.8% | +27.6% | +409.1% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +1,897.4% | +111.4% | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | +328.4% | -104.2% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.